Nabiqasim Industries

Nabiqasim Industries is a leading Pakistani pharmaceutical manufacturer with over five decades of experience. The company specializes in branded generic formulations and microencapsulated APIs, serving both domestic and international markets. Its manufacturing facility in Karachi operates under cGMP standards and ISO certifications. The company has a diverse portfolio covering cardiology, surgery, orthopaedics, paediatrics, gynaecology, neurology, dermatology, psychiatry, ENT and ophthalmology. It exports to the Middle East, Far East Asia, Central Asia and Africa. Notably involved in contract/custom manufacturing as well as its own R&D pipeline; one known clinical program involves misoprostol targeting the prostanoid EP2 receptor for nonalcoholic steatohepatitis at Phase 2.